Jefferies Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$9.35M Buy
46,726
+29,831
+177% +$5.97M 0.08% 76
2022
Q2
$2.46M Sell
16,895
-2,893
-15% -$422K 0.02% 282
2022
Q1
$3.23M Sell
19,788
-12,171
-38% -$1.99M 0.02% 265
2021
Q4
$5.42M Buy
31,959
+18,515
+138% +$3.14M 0.03% 195
2021
Q3
$2.54M Sell
13,444
-3,096
-19% -$585K 0.02% 358
2021
Q2
$2.8M Buy
+16,540
New +$2.8M 0.02% 374
2021
Q1
Sell
-18,704
Closed -$2.43M 1090
2020
Q4
$2.43M Buy
18,704
+5,186
+38% +$674K 0.02% 336
2020
Q3
$1.97M Sell
13,518
-26
-0.2% -$3.79K 0.02% 314
2020
Q2
$2.01K Sell
13,544
-3,460
-20% -$512 0.02% 301
2020
Q1
$1.85M Buy
17,004
+5,184
+44% +$564K 0.02% 327
2019
Q4
$1.36M Buy
11,820
+8,607
+268% +$991K 0.01% 671
2019
Q3
$258K Buy
+3,213
New +$258K ﹤0.01% 1355
2018
Q4
Sell
-31,102
Closed -$2.72M 1390
2018
Q3
$2.72M Buy
31,102
+30,702
+7,676% +$2.69M 0.02% 385
2018
Q2
$39K Sell
400
-25,995
-98% -$2.53M ﹤0.01% 1486
2018
Q1
$3.14M Buy
26,395
+11,895
+82% +$1.42M 0.02% 314
2017
Q4
$1.84M Buy
14,500
+2,000
+16% +$254K 0.01% 540
2017
Q3
$1.47M Buy
+12,500
New +$1.47M 0.01% 560
2016
Q3
Hold
0
1275
2016
Q2
Sell
-1,700
Closed -$107K 1236
2016
Q1
$107K Sell
1,700
-11,514
-87% -$725K ﹤0.01% 1101
2015
Q4
$1.24M Buy
13,214
+918
+7% +$86.4K 0.01% 425
2015
Q3
$988K Sell
12,296
-65,100
-84% -$5.23M 0.01% 547
2015
Q2
$9.28M Buy
77,396
+15,072
+24% +$1.81M 0.05% 84
2015
Q1
$6.51M Buy
+62,324
New +$6.51M 0.04% 120
2014
Q2
Sell
-1,053
Closed -$71K 1381
2014
Q1
$71K Buy
+1,053
New +$71K ﹤0.01% 1172
2013
Q3
Sell
-60,079
Closed -$1.86M 1225
2013
Q2
$1.86M Buy
+60,079
New +$1.86M 0.02% 204